Parallel Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

Parallel Advisors, LLC

$4.87 Billion
Q2 2025

A detailed history of Parallel Advisors, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 42 shares of ACAD stock, worth $992. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 107 60.75%

Holding current value

$992

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 07, 2025	SELL	$14.1 - $22.95 $916 - $1,491	-65 Reduced 60.75%	42 $0
Q1 2025 Apr 07, 2025	SELL	$16.61 - $20.29 $564 - $689	-34 Reduced 24.11%	107 $1,000
Q4 2024 Feb 10, 2025	BUY	$14.29 - $18.76 $1,186 - $1,557	83 Added 143.1%	141 $2,000
Q3 2024 Nov 13, 2024	BUY	$15.14 - $19.14 $878 - $1,110	58 New	58 $0
Q4 2023 Feb 09, 2024	SELL	$20.78 - $31.77 $2,701 - $4,130	-130 Reduced 40.12%	194 $6,000
Q3 2023 May 20, 2024	BUY	$20.84 - $33.47 $3,376 - $5,422	162 Added 100.0%	324 $6,000
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $3,376 - $5,422	162 Added 100.0%	324 $6,000
Q1 2023 May 20, 2024	SELL	$16.32 - $20.92 $522 - $669	-32 Reduced 16.49%	162 $3,000
Q4 2022 Feb 03, 2023	SELL	$14.2 - $18.63 $1,306 - $1,713	-92 Reduced 36.22%	162 $2,000
Q3 2022 Nov 10, 2022	BUY	$14.11 - $18.27 $1,142 - $1,479	81 Added 46.82%	254 $4,000
Q2 2022 Aug 01, 2022	SELL	$13.01 - $27.22 $4,176 - $8,737	-321 Reduced 64.98%	173 $2,000
Q1 2022 Apr 28, 2022	SELL	$20.94 - $27.5 $18,238 - $23,952	-871 Reduced 63.81%	494 $12,000
Q4 2021 Jan 20, 2022	BUY	$16.79 - $27.09 $9,805 - $15,820	584 Added 74.78%	1,365 $32,000
Q3 2021 Nov 02, 2021	BUY	$15.78 - $24.77 $7,274 - $11,418	461 Added 144.06%	781 $13,000
Q2 2021 Aug 06, 2021	BUY	$19.4 - $27.42 $853 - $1,206	44 Added 15.94%	320 $8,000
Q1 2021 Apr 23, 2021	BUY	$25.02 - $54.99 $2,376 - $5,224	95 Added 52.49%	276 $7,000
Q4 2020 Feb 02, 2021	BUY	$41.04 - $56.79 $123 - $170	3 Added 1.69%	181 $10,000
Q3 2020 Oct 27, 2020	BUY	$36.42 - $57.0 $582 - $912	16 Added 9.88%	178 $7,000
Q3 2018 Nov 01, 2018	BUY	$13.03 - $21.81 $1,680 - $2,813	129 Added 390.91%	162 $3,000
Q2 2018 Jul 30, 2018	SELL	$15.07 - $22.34 $2,561 - $3,797	-170 Reduced 83.74%	33 $0
Q1 2018 May 08, 2018	BUY	$22.47 - $32.33 $741 - $1,066	33 Added 19.41%	203 $5,000
Q3 2017 Nov 15, 2017	BUY	$29.49 - $38.37 $5,013 - $6,522	170 New	170 $5,000
Q3 2017 Nov 14, 2017	SELL	$29.49 - $38.37 $5,013 - $6,522	-170 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	170	170 $5,000

Others Institutions Holding ACAD

# of Institutions

351

Shares Held

163M

Call Options Held

1.77M

Put Options Held

307K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.83B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Acadia Pharmaceuticals Inc Transaction History